When Is Derm Helpful for Inpatient Skin Biopsy?

Quick answer

Biopsy-Sensitive Rash

• Derm discussion is reasonable when biopsy site, timing, depth, specimen handling, DIF, or tissue culture could change diagnostic yield. [1]
• Bullous disease, vasculitis, autoimmune connective tissue disease, atypical infection, and malignancy concern are high-yield categories.
• If a lesion is stable and outpatient biopsy timing is safe, inpatient Derm may not be needed.

Derm discussion is reasonable when

Higher-Yield Consult Context

• Bullous disease where lesional and perilesional/DIF technique may matter.
• Suspected vasculitis, retiform purpura, or vasculopathy where lesion age and site may matter.
• Atypical infection where tissue culture/biopsy site selection changes ID strategy.
• Possible malignancy or CTCL where biopsy site selection changes workup.

Workup or another service usually comes first when

Better First Step

• Patient instability or source control concern requires emergency pathway first.
• Routine outpatient lesion without disposition relevance can often wait for outpatient biopsy.
• The question is nonspecific and no morphology, distribution, photos, or lesion age is available.

Common pitfall

Keep the Question Specific

The wrong biopsy site or specimen handling can make a high-value biopsy low yield. Ask what diagnosis the biopsy is meant to separate.

Before you consult

Make the Biopsy Question Useful

• Upload photos and document morphology, distribution, lesion age, immune status, medication timeline, and the diagnosis the biopsy is meant to separate.
• If the lesion is stable and outpatient biopsy timing is safe, outpatient Dermatology may be the better first step.
• Ask Derm what they can change: biopsy site, timing, depth, DIF handling, tissue culture, disposition, or follow-up timing.